How Much Does Sculptra Cost? Price per Vial

Sculptra is not a prefilled syringe of gel the way hyaluronic acid fillers are.

It is supplied as a freeze-dried powder of poly-L-lactic acid microparticles in 367.5 mg vials — one vial for a single patient and a single session — and each vial must be mixed with sterile water before it can be injected.

Sculptra is counted in vials, so "price per vial" is the number to ask an office for.

What we cannot give you is a verified per-vial figure.

ASPS's cost page averages Sculptra's whole category rather than pricing the product by name, and the consumer review-site cost pages our researchers tried to read — RealSelf's Sculptra page among them — were blocked when we checked on October 16, 2026.

This page quotes no per-vial price because we could not confirm one, not because the number does not exist.

The figure that is on the record is a category average: ASPS lists $901 as the average cost for non-hyaluronic acid fillers, with Radiesse, Sculptra and Bellafill as its examples, alongside $715 for hyaluronic acid fillers and $743 for lip augmentation with filler.

These are average fees reported by ASPS member plastic surgeons — not med spa prices — and the page does not state the data year, nor does ASPS say whether the fee is per syringe or per procedure.

There is no standard count to give you: we found no label, professional-body or peer-reviewed source that sets a standard number of vials for a face area.

What exists is the label's per-session maximums and the volumes used in Sculptra's own cheek-wrinkle study — both counted in milliliters, because the powder is reconstituted before injection.

The label caps a session at up to 9 mL per cheek — one vial reconstituted with 8 mL of sterile water — and up to 4.5 mL per nasolabial fold (smile line).

In the cheek-wrinkle study, subjects received at most two vials per session, one per side.

That study is also the fullest picture of a face course in the label.

Its 97 treated subjects were treated at four-week intervals for up to four sessions, and 67 of them went on to a fourth session.

The median volume per session was 16.0 mL across both cheeks, and the mean total was 54.11 mL per subject — about six of the 9 mL vials, an estimate from the label's own numbers rather than a dosing rule.

Those numbers cover only what Sculptra is approved for.

Its US approvals are HIV-associated facial fat loss (2004), shallow to deep nasolabial fold contour deficiencies and other facial wrinkles (2009, as Sculptra Aesthetic, in immune-competent people), and fine lines and wrinkles in the cheek region (2023).

There is no labeled vial count for temples, jawline or a full-face plan, because the label states that safety and effectiveness have not been evaluated in larger amounts, at different frequencies, or at sites other than its approved uses.

A Sculptra total has three moving parts: the price per vial, how many vials each session uses, and how many sessions your plan runs.

The label's cheek study fixes the shape of the last two — up to four sessions, four weeks apart — but the total still depends on the first part, and that is the number we could not confirm.

Any total you see online is only as reliable as the per-vial price it assumes, which is usually unstated.

ASPS's $901 is a single average fee, not a course total, and ASPS does not say whether the fee is per syringe or per procedure.

Sculptra's structure also spreads the vials across a series of visits: in the label's cheek study, sessions came at four-week intervals for up to four sessions, so the study's course ran across several appointments, not one.

Plan for the whole series when you compare prices.

A per-session quote and a whole-course quote are different numbers, and the office you consult is the source for both.

What the money buys — how results develop over weeks and what the trials measured — is the hub's side of the story: see the Sculptra guide, and the Sculptra before and after page for the timeline.

Body pricing is where Sculptra gets expensive and the evidence gets thin.

Buttock and hip injections are off-label: the approved uses are the facial ones above, and FDA goes further for body contouring, recommending against the use of any dermal filler to increase the size of the buttocks or breasts and stating that these uses are not FDA-approved.

The vial counts published for buttock use come from small, low-quality studies.

A 2020 review called the literature sparse, and a 2023 systematic review found only 12 reports on filler buttock augmentation, most strongly biased, warning that serious complications occur.

One retrospective series — 60 women, single-practice and uncontrolled — reported 1 to 3 sessions 4 to 6 weeks apart, with 2 to 12 vials per session chosen "based on the patient budget," and its authors concluded that visible results required at least 20 vials in total.

That is one study's reported experience, not a dosing standard — and there is no verified per-vial price to multiply it by, only your local quotes.

Local prices are local facts.

ASPS names what moves them: the injector's expertise and qualifications, the type of procedure, the time and effort required, and the geographic location of the office.

The offices you contact are the source for the number that matters — the national figures above are reference points, not quotes.

Two money facts hold wherever ASPS describes them: health insurance does not cover dermal fillers, and many plastic surgeons offer patient financing plans, so it is a fair question to ask.

Sculptra's maker runs its own rewards program.

Galderma's ASPIRE gave a $20-off welcome reward and 100 points equal to $10 in savings; Sculptra earns 200 points per vial, up to 600 points per visit, inside a 1,000-point per-visit treatment maximum and a 2,000-point annual earning limit.

Those are the program's terms as read on October 16, 2026, subject to ASPIRE's own terms and conditions — a points scheme, not a standing discount.

However low a quote is, FDA's advice sets the floor for who should be behind it: filler injection should be considered a medical procedure, not a cosmetic treatment, and FDA advises choosing a licensed health care provider with dermatology or plastic-surgery experience who is trained in filler injection.